Trial intelligence / Profile preview

Tulobuterol patch in pediatric tonsillectomy

NCT04057469Completed

Sponsor
Seoul National University Hospital
Start
Dec 2019
Primary completion
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in tonsillar hypertrophy comparing Tulobuterol patch with Placebo (2 arms). Primary endpoint: perioperative respiratory complication at 3 hours. Started Dec 2019; status: completed.

02

Drugs

tulobuterol
03

Conditions

tonsillar hypertrophy

Beyond the preview

Go deeper on NCT04057469.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04057469.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call